Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

29 Jan 2021 10:37

RNS Number : 3696N
Unicorn AIM VCT PLC
29 January 2021
Ā 

Unicorn AIM VCT plc ("the Company")

Interim Management StatementĀ 

For the period from 1 October 2020 to 31 December 2020

Ā 

Introduction

This voluntary Interim Management Statement (IMS) covers the three month period ended 31 December 2020, together with relevant information up to the date of publication.Ā 

Ā 

Investment Objective

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

Ā 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust ("VCT"), so that Shareholders benefit from the taxation advantages that this brings. To achieve this, at least 80% for accounting periods commencing on or after 6 April 2019 (previously 70%) of the Company's total assets are to be invested in qualifying investments of which 70%Ā by VCT value (30% in respect of investments made before 6 April 2018 from funds raised before 6 April 2011) must be in ordinary shares, which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

Ā 

Performance Ā 

The performance of the Company's diverse portfolio of investments, has been largely positive during the first quarter of the Company's current financial year. Net asset value per share increased significantly, as many of the companies held in the portfolio issued encouraging trading updates which, in turn, triggered some impressive share price gains.

Ā 

As at 31 December 2020, the unaudited net asset value was 204.5 pence per share, which represents an increase of +14.5% on the audited closing net asset value of 178.6 pence per share as at 30 September 2020. UK equity indices also continued their recovery from the significant equity market correction experienced during March 2020, with the FTSE AIM All-Share Index generating a total return of +20.9%, while the FTSE AllShare Index delivered a total return of +12.6% over the same period.

Ā 

The portfolio remains predominantly composed of investments in businesses listed on the Alternative Investment Market (AIM). Many of these investee companies are relatively mature and, as such, most have them have remained profitable throughout the difficulties experienced during 2020.

Ā 

Encouragingly, the pipeline of investment opportunities has strengthened since the start of October, and all key HMRC tests continued to be met. At the period end, an estimated 85.4% of total assets (assessed in accordance with VCT rules) were invested in VCT qualifying companies.

Ā 

Despite the increased risks associated with early-stage investment and the uncertainty created by the ongoing pandemic, the Investment Manager is confident that the portfolio, as a whole, offers the prospect of delivering attractive total returns over the longer term.

Ā 

Material Transactions

During the period under review, four new VCT qualifying investments, costing £6.3 million, were completed. No follow-on VCT qualifying investments were made.

Ā 

Approximately £0.4 million was raised from the partial disposal of one holding during the period. In addition, one holding was disposed of in full, realising proceeds of approximately £1.4 million. The usual purpose of such disposals is threefold; to ensure stock specific risk is contained, to lock in capital profits for future distribution to shareholders via dividend payments and to help manage liquidity requirements.

Ā 

Top Ten VCT Qualifying Holdings as at 31 December 2020

Stock

% of fund

Interactive Investor

10.7%

Hasgrove

9.6%

Abcam

6.4%

MaxCyte Inc

5.3%

Tracsis

3.5%

Anpario

3.2%

Tristel

2.9%

Surface Transforms

2.7%

Cohort

2.5%

Mattioli Woods

2.4%

Total

49.2%

Ā 

Share Buy-Backs

During the period from 1 October to 31 December 2020, the Company bought back 770,517 of its own Ordinary Shares for cancellation, at an average price of 162 pence per share. As at 31 December 2020, there were 144,962,024 Ordinary Shares in issue. After the period end, a further 131,796 Ordinary Shares were purchased for cancellation at a price of 174.5 pence per share.

Ā 

Dividends & Annual General Meeting

As previously advised, the Board declared a final dividend of 3.5 pence per share in respect of the Company's financial year ended 30 September 2020. This final dividend will be paid on 11 February 2021 to Shareholders who were on the register on 8 January 2021, subject to receiving approval from shareholders at the Annual General Meeting of the Company, which is to be held on 4 February 2021, in a closed format due to the ongoing Covid-19 pandemic.

Ā 

Material Events

There were no material events during the period under review.

An Offer for Subscription, to raise up to £15 million of new capital, opened on 28 January 2021 and will close for applications on 29 March 2021, or earlier, if fully subscribed.

Ā 

Chris Hutchinson

Director, Unicorn Asset Management

Ā 

29 January 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
STRFZGZMGLKGMZM
Date   Source Headline
14th Dec 20227:00 amRNSFinal Results
8th Dec 202210:12 amRNSIntention to Launch an Offer
5th Dec 20222:43 pmRNSNet Asset Value(s)
4th Nov 20225:47 pmRNSNet Asset Value(s)
21st Oct 20221:38 pmRNSNet Asset Value(s)
3rd Oct 202212:45 pmRNSTotal Voting Rights
20th Sep 20226:19 pmRNSTransaction in Own Shares
5th Sep 202212:32 pmRNSNet Asset Value(s)
11th Aug 202211:27 amRNSIssue of Equity
4th Aug 20222:47 pmRNSNet Asset Value(s)
26th Jul 202211:30 amRNSInterim Management Statement
7th Jul 20229:50 amRNSNet Asset Value(s)
1st Jul 202210:00 amRNSTotal Voting Rights
22nd Jun 20225:44 pmRNSTransaction in Own Shares
14th Jun 20223:27 pmRNSNet Asset Value(s)
10th Jun 20227:00 amRNSHalf-year Report
24th May 20222:26 pmRNSDirectorate Change
6th May 202212:33 pmRNSNet Asset Value(s)
11th Apr 20229:02 amRNSNet Asset Value(s) Replacement
7th Apr 20223:14 pmRNSNet Asset Value(s)
1st Apr 202210:43 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20221:40 pmRNSDirector/PDMR Shareholding
4th Mar 202212:44 pmRNSTotal Voting Rights
4th Mar 202212:39 pmRNSIssue of Equity
2nd Mar 20222:26 pmRNSNet Asset Value(s)
1st Mar 20229:58 amRNSTotal Voting Rights
18th Feb 20221:27 pmRNSInterim Management Statement
15th Feb 20224:51 pmRNSTransaction in Own Shares
10th Feb 20227:00 amRNSIssue of Equity
9th Feb 202212:11 pmRNSOffer for Subscription - Update
7th Feb 202210:12 amRNSNet Asset Value(s)
3rd Feb 20221:34 pmRNSResult of AGM
1st Feb 202211:52 amRNSTotal Voting Rights
24th Jan 202210:17 amRNSOffer for Subscription and Issue of Prospectus
17th Jan 202212:44 pmRNSTransaction in Own Shares
6th Jan 20222:49 pmRNSNet Asset Value(s)
4th Jan 20229:41 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSTransaction in Own Shares
16th Dec 202112:33 pmRNSConfirmation of Dividends
14th Dec 20211:48 pmRNSNet Asset Value(s)
8th Dec 20217:00 amRNSFinal Results
22nd Nov 20215:07 pmRNSDeclaration of Special Dividend
4th Nov 20215:47 pmRNSNet Asset Value(s)
26th Oct 20213:07 pmRNSIntention to launch an Offer
18th Oct 20214:34 pmRNSNet Asset Value(s)
1st Oct 202111:46 amRNSTotal Voting Rights
10th Sep 20213:52 pmRNSTransaction in Own Shares
1st Sep 20212:46 pmRNSTotal Voting Rights
16th Aug 202110:57 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.